Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04846582
Other study ID # AMY007BR
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 28, 2021
Est. completion date January 10, 2023

Study information

Verified date September 2023
Source Chugai Pharmaceutical
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to confirm the reproducibility that the MEDL score can be evaluated by Magnetic Resonance Imaging (MRI) in the similar way as laparoscopy, the gold standard for the evaluation of the disease state of endometriosis, in order to establish the MEDL score, a new evaluation index for endometriosis using MRI. Approximately 70-90 patients with endometriosis diagnosed by imaging and who are candidates for fertility-preserving surgery will be recruited retrospectively or prospectively, and the disease status of endometriosis will be evaluated using preoperative MR images, laparoscopic surgery videos, etc. The relationship between the condition and clinical symptoms, such as pain, is also considered.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date January 10, 2023
Est. primary completion date January 10, 2023
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Patients who consent to use their data in this study - Patients with endometriosis diagnosed by transvaginal ultrasound (TVUS) and/or MRI - Patients undergoing fertility-preserving surgery - Patients with pain due to endometriosis - Patients with endometriotic lesions other than ovarian cysts confirmed by MRI (concomitant ovarian cysts can be recruited) - Patients with the following patient clinical information (TVUS is not mandatory when archived data is used) Patient clinical information: Preoperative MR images, videos of laparoscopic surgery, pathological evaluation of endometriosis, videos of preoperative TVUS, pain information related to endometriosis, information about infertility before surgery, information on QOL, information on postoperative recurrence, information on surgical difficulty, operating time, length of hospital stay for surgical operation, age, history of treatment (drugs, surgery), anamnesis and complication, history of endometriosis, age at menarche, menstrual cycle, date of surgery, date of MR image acquisition, operative procedure and history of pregnancy and childbirth. Exclusion Criteria: - Patients who had surgery for endometriosis prior to the surgery included in this study - Patients deemed inappropriate by the principal investigator - Patients who obtained their voluntary consent but later withdrew their consent

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Brazil Clinica Medicina da Mulher São Sebastião São Paulo

Sponsors (2)

Lead Sponsor Collaborator
Chugai Pharmaceutical Clinica Medicina da Mulher

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation of MEDL score assessed by MRI and laparoscopy Correlation coefficient of total MEDL score assessed by preoperative MRI and laparoscopy at the time of surgery
Secondary Association of MRI findings by MEDL score with pain Correlation coefficient between preoperative pain Visual Analog Scale (VAS) score and total MEDL score preoperative
Secondary Association of MRI findings by MEDL score with infertility Relationship between presence or absence of infertility and total MEDL score preoperative
Secondary Association of MRI findings by MEDL score with SF-36 Relationship between responses to the SF-36 questionnaire and total MEDL score preoperative
Secondary Association of MRI findings by MEDL score with Endometriosis Health Profile Questionnaire-30 (EHP-30) Relationship between responses to the EHP-30 questionnaire and total MEDL score preoperative
Secondary Association of MRI findings by MEDL score with postoperative recurrence Relationship between presence or absence of postoperative recurrence from surgery to obtaining informed consent, assessed up to 3 years (for retrospective data collection)
Secondary Association of MRI findings by MEDL score with Ultrasound-based Endometriosis Staging System (UBESS) Relationship between stage of UBESS and total MEDL score preoperative
Secondary Association of MRI findings by MEDL score with operating time Relationship between hospital stay and total MEDL score at the time of surgery
Secondary Association of MRI findings by MEDL score with hospital stay Relationship between hospital stay and total MEDL score at the time of surgery
Secondary Agreement rate among evaluators using the MEDL score The agreement rate for each evaluation item of MEDL score when multiple evaluators evaluated at the time of preoperative MR imaging
Secondary K coefficient among evaluators using the MEDL score K coefficient for each evaluation item of MEDL score when multiple evaluators evaluated at the time of preoperative MR imaging
Secondary Concordance between laparoscopic findings and transvaginal ultrasound findings using the MEDL score Correlation coefficient of total MEDL score assessed by preoperative transvaginal ultrasound and laparoscopy at the time of surgery
Secondary Association of MRI findings by MEDL score with rASRM score evaluated by laparoscopy Correlation coefficient of total MEDL score assessed by preoperative MRI and rASRM score assessed by laparoscopy at the time of surgery
Secondary Association of MRI findings by MEDL score with ENZIAN classification evaluated by laparoscopy and MRI Association between total MEDL score assessed by preoperative MRI and ENZIAN classification assessed by laparoscopy at the time of surgery
See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4